Literature DB >> 8818956

An ovine CFTR variant as a putative cystic fibrosis causing mutation.

S J Tebbutt1, A Harris, D F Hill.   

Abstract

This report describes a DNA variant in the ovine cystic fibrosis transmembrane conductance regulator (CFTR) gene that has been previously reported as a putative cystic fibrosis causing mutation in humans. The variant is a guanine to adenine base change at position 1019 of the ovine CFTR cDNA, corresponding to an arginine (R) to glutamine (Q) amino acid substitution at position 297 in the predicted CFTR polypeptide. The equivalent R297Q mutation in exon 7 of the human CFTR gene has been reported in a CF patient. This is the first putative cystic fibrosis mutation to be detected in another animal species.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818956      PMCID: PMC1050678          DOI: 10.1136/jmg.33.7.623

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene.

Authors:  G Chalkley; A Harris
Journal:  J Med Genet       Date:  1991-11       Impact factor: 6.318

2.  French CF family genotype analysis shows that the R297Q mutation is a rare polymorphism.

Authors:  I Dorval; P Jézéquel; B Chauvel; C Dubourg; P Fergelot; J Y Le Gall; M Roussey; M Blayau
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Generation and characterization of a delta F508 cystic fibrosis mouse model.

Authors:  W H Colledge; B S Abella; K W Southern; R Ratcliff; C Jiang; S H Cheng; L J MacVinish; J R Anderson; A W Cuthbert; M J Evans
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

5.  CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP.

Authors:  E M Schwiebert; M E Egan; T H Hwang; S B Fulmer; S S Allen; G R Cutting; W B Guggino
Journal:  Cell       Date:  1995-06-30       Impact factor: 41.582

6.  Cystic fibrosis in the mouse by targeted insertional mutagenesis.

Authors:  J R Dorin; P Dickinson; E W Alton; S N Smith; D M Geddes; B J Stevenson; W L Kimber; S Fleming; A R Clarke; M L Hooper
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

7.  Identification and developmental expression of the Xenopus laevis cystic fibrosis transmembrane conductance regulator gene.

Authors:  S J Tucker; D Tannahill; C F Higgins
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

8.  Identification of rare and novel mutations in the CFTR genes of CF patients in southern England.

Authors:  S Shackleton; J Hull; S Dear; A Seller; A Thomson; A Harris
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  Molecular analysis of the ovine cystic fibrosis transmembrane conductance regulator gene.

Authors:  S J Tebbutt; C J Wardle; D F Hill; A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

  9 in total
  2 in total

Review 1.  Biomedical and agricultural applications of animal transgenesis.

Authors:  Alison J Thomson; Jim McWhir
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

2.  The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection.

Authors:  K A Brogden; V C Kalfa; M R Ackermann; D E Palmquist; P B McCray; B F Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.